I have a medical background and have long felt a sepsis trial could be quick to demonstrate efficacy; with success it would be on the formulary of every hospital and get used as a per protocol intervention with IV route. There are some fairly well defined triggers to call a code sepsis which is going to activate fluid loading, antibiotics etc. and mortality is very high. Unlike cancer where you are looking at a long period for trial readout you would know status of each patient quickly. Unfortunately company appears in stasis with regard to any new trials as a cash conservation measure or perhaps waiting on some other news yet to be revealed. Whatever happens with Cytodyn at some point it should be trialed for this indication…I agree with OHM it is highly likely to work…and is needed by humanity…same argument as cancer, Nash etc., just that smoking gun efficacy link would be quick and likely unequivocal and indisputable.